{"id":"https://openalex.org/W4405374366","doi":"https://doi.org/10.1016/j.iotech.2024.100789","title":"160P Oral DNA vaccination targeting personalised neoantigens in immune checkpoint-inhibitor treated solid tumor patients: Interim results","display_name":"160P Oral DNA vaccination targeting personalised neoantigens in immune checkpoint-inhibitor treated solid tumor patients: Interim results","publication_year":2024,"publication_date":"2024-12-01","ids":{"openalex":"https://openalex.org/W4405374366","doi":"https://doi.org/10.1016/j.iotech.2024.100789"},"language":"en","primary_location":{"id":"doi:10.1016/j.iotech.2024.100789","doi":"https://doi.org/10.1016/j.iotech.2024.100789","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2024.100789","pdf_url":"https://www.esmoiotech.org/article/S2590-0188(24)00086-8/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.esmoiotech.org/article/S2590-0188(24)00086-8/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031393517","display_name":"Domas Vaitiekus","orcid":"https://orcid.org/0000-0002-9583-4475","observed_orcids":["https://orcid.org/0000-0002-9583-4475"]},"institutions":[{"id":"https://openalex.org/I131736796","display_name":"Lithuanian University of Health Sciences","ror":"https://ror.org/0069bkg23","country_code":"LT","type":"education","lineage":["https://openalex.org/I131736796"]}],"countries":["LT"],"is_corresponding":false,"raw_author_name":"D. Vaitiekus","raw_affiliation_strings":["Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania","institution_ids":["https://openalex.org/I131736796"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013477981","display_name":"Elona Juozaityt\u0117","orcid":"https://orcid.org/0000-0001-6695-7786","observed_orcids":["https://orcid.org/0000-0001-6695-7786"]},"institutions":[{"id":"https://openalex.org/I131736796","display_name":"Lithuanian University of Health Sciences","ror":"https://ror.org/0069bkg23","country_code":"LT","type":"education","lineage":["https://openalex.org/I131736796"]}],"countries":["LT"],"is_corresponding":false,"raw_author_name":"E. Juozaityte","raw_affiliation_strings":["Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania","institution_ids":["https://openalex.org/I131736796"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115434093","display_name":"L. Puzauskien\u0117","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I131736796","display_name":"Lithuanian University of Health Sciences","ror":"https://ror.org/0069bkg23","country_code":"LT","type":"education","lineage":["https://openalex.org/I131736796"]},{"id":"https://openalex.org/I2802445891","display_name":"Hospital of Lithuanian University of Health Sciences Kaunas Clinics","ror":"https://ror.org/058hsp657","country_code":"LT","type":"healthcare","lineage":["https://openalex.org/I131736796","https://openalex.org/I2802445891"]}],"countries":["LT"],"is_corresponding":false,"raw_author_name":"L. Puzauskien\u0117","raw_affiliation_strings":["Oncology Department, Kauno Klinikos - The Hospital of Lithuanian University of Health Sciences (LSMU), Kaunas, Lithuania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Kauno Klinikos - The Hospital of Lithuanian University of Health Sciences (LSMU), Kaunas, Lithuania","institution_ids":["https://openalex.org/I131736796","https://openalex.org/I2802445891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071964732","display_name":"Skaist\u0117 Tulyt\u0117","orcid":"https://orcid.org/0000-0003-2288-8402","observed_orcids":["https://orcid.org/0000-0003-2288-8402"]},"institutions":[{"id":"https://openalex.org/I173212132","display_name":"Vilnius University","ror":"https://ror.org/03nadee84","country_code":"LT","type":"education","lineage":["https://openalex.org/I173212132"]},{"id":"https://openalex.org/I4210161607","display_name":"Vilnius University Hospital Santariskiu Klinikos","ror":"https://ror.org/0590pq693","country_code":"LT","type":"healthcare","lineage":["https://openalex.org/I4210161607"]}],"countries":["LT"],"is_corresponding":false,"raw_author_name":"S. Tulyte","raw_affiliation_strings":["Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania","institution_ids":["https://openalex.org/I173212132","https://openalex.org/I4210161607"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115434094","display_name":"L. Gatijatullin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153145","display_name":"National Cancer Institute","ror":"https://ror.org/04w2jh416","country_code":"LT","type":"healthcare","lineage":["https://openalex.org/I4210153145"]}],"countries":["LT"],"is_corresponding":false,"raw_author_name":"L. Gatijatullin","raw_affiliation_strings":["Department of Oncology, National Cancer Institute, Vilnius, Lithuania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, National Cancer Institute, Vilnius, Lithuania","institution_ids":["https://openalex.org/I4210153145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064778456","display_name":"Michael Platten","orcid":"https://orcid.org/0000-0002-4746-887X","observed_orcids":["https://orcid.org/0000-0002-4746-887X"]},"institutions":[{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Platten","raw_affiliation_strings":["Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany","institution_ids":["https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038539225","display_name":"Isabel C. Poschke","orcid":"https://orcid.org/0000-0002-4387-5566","observed_orcids":["https://orcid.org/0000-0002-4387-5566"]},"institutions":[{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"I. Poschke","raw_affiliation_strings":["Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany","institution_ids":["https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002843682","display_name":"Ingrid H\u00fclsmeyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"I. Hulsmeyer","raw_affiliation_strings":["Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany","institution_ids":["https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Kuhn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Kuhn","raw_affiliation_strings":["NEC Bio Therapeutics GmbH, Mannheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEC Bio Therapeutics GmbH, Mannheim, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021949493","display_name":"A. Aranguren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Aranguren","raw_affiliation_strings":["NEC Bio Therapeutics GmbH, Mannheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEC Bio Therapeutics GmbH, Mannheim, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031256236","display_name":"Heinz Lubenau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Lubenau","raw_affiliation_strings":["NEC Bio Therapeutics GmbH, Mannheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEC Bio Therapeutics GmbH, Mannheim, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026963955","display_name":"Hugues Fontenelle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Fontenelle","raw_affiliation_strings":["PCV, NEC OncoImmunity AS, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PCV, NEC OncoImmunity AS, Oslo, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033753429","display_name":"Boris Simovski","orcid":"https://orcid.org/0000-0002-3629-1570","observed_orcids":["https://orcid.org/0000-0002-3629-1570"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Simovski","raw_affiliation_strings":["Data Science, NEC OncoImmunity AS, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Science, NEC OncoImmunity AS, Oslo, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031962020","display_name":"Yuka Iijima Yamashita","orcid":"https://orcid.org/0000-0001-8452-8950","observed_orcids":["https://orcid.org/0000-0001-8452-8950"]},"institutions":[{"id":"https://openalex.org/I118347220","display_name":"NEC (Japan)","ror":"https://ror.org/04jndar25","country_code":"JP","type":"company","lineage":["https://openalex.org/I118347220"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Yamashita","raw_affiliation_strings":["NEC Corporation, NEC Corporation, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEC Corporation, NEC Corporation, Tokyo, Japan","institution_ids":["https://openalex.org/I118347220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032171465","display_name":"Catherine Chaput","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164122","display_name":"NEC (Germany)","ror":"https://ror.org/05hxss661","country_code":"DE","type":"company","lineage":["https://openalex.org/I118347220","https://openalex.org/I4210164122"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C. Chaput","raw_affiliation_strings":["Biomedical AI, NEC Laboratories Europe GmbH, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical AI, NEC Laboratories Europe GmbH, Heidelberg, Germany","institution_ids":["https://openalex.org/I4210164122"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083632920","display_name":"Andrea Meiser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164122","display_name":"NEC (Germany)","ror":"https://ror.org/05hxss661","country_code":"DE","type":"company","lineage":["https://openalex.org/I118347220","https://openalex.org/I4210164122"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Meiser","raw_affiliation_strings":["Biomedical AI, NEC Laboratories Europe GmbH, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical AI, NEC Laboratories Europe GmbH, Heidelberg, Germany","institution_ids":["https://openalex.org/I4210164122"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078185518","display_name":"Vincas Urbonas","orcid":"https://orcid.org/0000-0002-8070-6163","observed_orcids":["https://orcid.org/0000-0002-8070-6163"]},"institutions":[{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"V. Urbonas","raw_affiliation_strings":["Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany","institution_ids":["https://openalex.org/I4210111460"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3170,"currency":"USD","value_usd":3170},"apc_paid":{"value":3170,"currency":"USD","value_usd":3170},"fwci":0.1459,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.35407499,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"24","issue":null,"first_page":"100789","last_page":"100789"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5497999787330627,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5497999787330627,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.448199987411499,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-vaccine","display_name":"DNA vaccine","score":0.8889999985694885},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.75},{"id":"https://openalex.org/keywords/tumor-specific-antigens","display_name":"tumor-specific antigens","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.8390392065048218},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.6954540014266968},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6025515794754028},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5985276103019714},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4546395540237427},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42838963866233826},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3943054974079132},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.14351877570152283},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.07899287343025208},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.iotech.2024.100789","doi":"https://doi.org/10.1016/j.iotech.2024.100789","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2024.100789","pdf_url":"https://www.esmoiotech.org/article/S2590-0188(24)00086-8/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.iotech.2024.100789","doi":"https://doi.org/10.1016/j.iotech.2024.100789","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2024.100789","pdf_url":"https://www.esmoiotech.org/article/S2590-0188(24)00086-8/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405374366.pdf","grobid_xml":"https://content.openalex.org/works/W4405374366.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7117308045","https://openalex.org/W7117301599","https://openalex.org/W3033261150","https://openalex.org/W4402561898","https://openalex.org/W4405374115","https://openalex.org/W3173588512","https://openalex.org/W4417175387","https://openalex.org/W7117299434","https://openalex.org/W4283643600","https://openalex.org/W2763711180"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2024-12-14T00:00:00"}